Skip to content

VTRS

Viatris Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$16.88
−0.35%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue14.7B14.3B14.7B15.4B16.3B
Cost of Revenue9.6B9.3B9.1B9.0B9.8B
Gross Profit5.1B5.0B5.6B6.4B6.5B
Operating Expenses
R&D Expense1.0B965.9M808.7M805.2M662.2M
SG&A Expense4.0B3.8B4.4B4.7B4.2B
General & Admin Expense1.1B
Selling & Marketing Expense
Other Expenses221.5M2.9B379.2M217.1M40.8M
Total Operating Expenses5.2B7.7B5.6B5.7B4.9B
Cost and Expenses14.8B17.0B14.7B14.7B14.6B
Operating Income (EBIT)(87.3M)(2.7B)10.1M766.2M1.6B
Non-Operating
Interest Income
Interest Expense480.0M471.3M550.0M573.1M592.4M
Net Interest Income(480.0M)(471.3M)(550.0M)(573.1M)(592.4M)
Other Non-Op Income/Expense(574.9M)(1.0B)(633.3M)(563.3M)1.2B
Non-Operating Income (excl Interest)(100.0K)530.6M83.3M(9.8M)(1.8B)
EBT (Pre-Tax Income)(662.2M)(3.7B)(623.2M)202.9M2.8B
Income Tax Expense(251.5M)(150.1M)11.0M148.2M734.6M
Bottom Line
Net Income(410.7M)(3.5B)(634.2M)54.7M2.1B
Earnings from Cont. Ops(410.7M)(3.5B)(634.2M)54.7M2.1B
Earnings from Discont. Ops
Bottom Line Net Income(410.7M)(3.5B)(634.2M)54.7M2.1B
Per Share
Basic EPS($0.36)($3.00)($0.53)$0.05$1.71
Diluted EPS($0.36)($3.00)($0.53)$0.05$1.71
Revenue Per Share$12.67$12.21$12.35$12.85$13.42
Shares
Basic Shares Outstanding1.2B1.2B1.2B1.2B1.2B
Diluted Shares Outstanding1.2B1.2B1.2B1.2B1.2B
Profitability Metrics
EBITDA2.6B(395.4M)2.8B3.5B6.4B
D&A2.7B2.8B2.9B2.7B3.0B
EBIT(87.2M)(3.2B)(73.2M)776.0M3.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026